$TLPH SEC Filings

Filed On	Filing
12 Aug 2026	FORM S-8
12 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	FORM 10-Q
12 Aug 2026	8-K: Results of Operations and Financial Condition
24 Jun 2026	Form 4: Wan Mark A, Director Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)
24 Jun 2026	Form 4: Todisco Joseph, Director Received 5,100 shares as a grant or award · Granted 30,700 Director Stock Option (right to buy)
24 Jun 2026	Form 4: Jain Abhinav, Director Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)
24 Jun 2026	Form 4: Hoffman Stephen J, Director Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)
24 Jun 2026	Form 4: Broadfoot Jill Marie, Director Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)
24 Jun 2026	Form 4: Bozilenko Marina, Director Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)
24 Jun 2026	Form 4: Adams Adrian, Director Received 5,100 shares as a grant or award · Granted 30,700 Stock Option (Right to Buy)
23 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
21 May 2026	Form 4: Aslam Shakil, Chief Medical Officer Gave up 4,518 shares to cover exercise price or tax ($3.72K)
15 May 2026	SCHEDULE 13G/A
13 May 2026	FORM 10-Q
13 May 2026	8-K: Results of Operations and Financial Condition
12 May 2026	SCHEDULE 13G/A
29 Apr 2026	FORM DEFA14A
29 Apr 2026	Proxy statement: annual meeting on June 22, 2026 CEO pay $1.1M, up 7.5% · say-on-pay vote
03 Apr 2026	Form 4: Angotti Vincent J., Director Gave up 9,938 shares to cover exercise price or tax ($7.18K)

Comments